AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.16
-0.54 (-0.97%)
At close: Sep 10, 2026, 4:00 PM EDT
54.39
-0.77 (-1.40%)
After-hours: Sep 10, 2026, 5:36 PM EDT

AnaptysBio Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Reiterates
n/a
BuyReiteratesn/an/aAug 24, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$95
BuyReiterates$95+72.23%Aug 24, 2026
Barclays
Barclays
Buy
Maintains
$75
BuyMaintains$75+35.97%Jul 31, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$93
BuyMaintains$93+68.60%Jul 21, 2026
UBS
UBS
Buy
Maintains
$76
BuyMaintains$76+37.78%Jul 1, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 27, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$69$70
BuyMaintains$69$70+26.90%May 23, 2026
Wedbush
Wedbush
Buy
Reiterates
$60$75
BuyReiterates$60$75+35.97%Mar 31, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.